TWiV 1034: Clinical update with Dr. Daniel Griffin

In his weekly clinical update, Dr. Griffin discusses the immunogenicity, safety, and preliminary efficacy evaluation of OVX836, a nucleoprotein-based universal influenza A vaccine candidate, association between nose picking and SARS-CoV-2 incidence, a cohort study in hospital health care workers; effect of COVID-19 vaccination and booster on maternal-fetal outcomes, dynamics of inflammatory responses after SARS-CoV-2 infection by vaccination status in the USA, does monoclonal antibody treatment for COVID-19 impact short and long- term outcomes in a large generalizable population, persistent endothelial dysfunction in post-COVID-19 syndrome and its associations with symptom severity and chronic inflammation, core mitochondrial genes are down-regulated during SARS-CoV-2 infection of rodent and human hosts. Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Immunogenicity, safety, and preliminary efficacy evaluation of OVX836, a influenza A vaccine candidate (The Lancet) Association between nose picking and SARS-CoV-2 incidence (PLOSONE) Effect of COVID-19 vaccination and booster on maternal-fetal outcomes (Lancet Digital Health) Dynamics of inflammatory responses after SARS-CoV-2 infection by vaccination status (The Lancet) Does monoclonal antibody treatment for COVID-19 impact short and long-term outcomes (BMJ) Persistent endothelial dysfunction in post-COVID-19 syndrome and its associations with symptom severity and inflammation (Angiogenesis) Core mitochondrial genes are down-regulated during SARS-CoV-2 infection of rodent and human hosts (STM) Contribute to our Floating Doctors fundraiser at PWB Letters read on TWiV 1034 Dr. Griffin’s COVID treatment summary (pdf) Timestamps by Jolene. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to [email protected]